⌕
Alkermes · ALKS · Nasdaq
Tenet 37 · Weak
Compare
$47.03+0.11%At closeTenet 37 · Weak
$47.03+0.05 (+0.11%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Alkermes (ALKS) Stock

Alkermes (ALKS) closed at $47.03 on Nov 13, 2026; its Tenet Score is 37 of 100 against 297 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

6 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$47.03
Nov 13, 2026
Market cap
$7.9B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
27.00 – 55.67
low → high · as of close, Nov 13, 2026
Tenet Score
37/100
Weak · 297 Healthcare peers

Industry: Drugs

Alkermes plc scores 37/100. Weak. Financial health is the soft spot versus 297 Healthcare peers.

Tenet Score · vs sector

n=297
37/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
25
Quality
51
Health
25
Growth
47

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityCHealthFGrowthDMomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
4.2×
price to book value
P/S
4.5×
price to fiscal 2025 sales
ROE
0%
return on equity
Operating margin
17.2%
fiscal 2025, before interest and tax
Net margin
0.0%
of revenue kept
Current ratio
2.42
current assets to liabilities
Net debt / EBITDA
5.1×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Alkermes plc

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products inc…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=297) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 148 US ETFs · top wrappers by weightSee all ETFs holding ALKS →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Alkermes in?

Alkermes is in the Healthcare sector and the Drugs industry.

What is Alkermes' Tenet Score?

Alkermes' Tenet Score is 37 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.